Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Greipp

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Seminars in Oncology|September 1, 1986
Treatment of refractory multiple myeloma and considerations for future therapyR A Kyle, P R Greipp, M A Gertz
Blood|January 15, 1991
Response rates and survival in primary systemic amyloidosisM A Gertz, R A Kyle, P R Greipp
Cancer Research|August 1, 1986
Elevated glucocorticoid receptor binding in cultured human lymphoblasts following hydroxyurea treatment: lack of effect on steroid responsivenessB A Littlefield, H C Hoagland, P R Greipp
Mayo Clinic Proceedings|July 1, 1981
The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literatureR A Kyle, P R Greipp, P M Banks
Blood|August 15, 1989
The plasma cell labeling index: a valuable tool in primary systemic amyloidosisM A Gertz, R A Kyle, P R Greipp
Medical and Pediatric Oncology|January 1, 1989
Phase II trial of amsacrine in patients with multiple myelomaP R Greipp, M Coleman, K Anderson, et al.
Leukemia & Lymphoma|June 1, 2000
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disordersT E Witzig, C Meyers, T Therneau, et al.
American Journal of Hematology|May 20, 1998
Primary plasmacytoma at the site of exit wounds after electrical injuryW Mongkonsritragoon, R A Kyle, R R Shreck, et al.
Leukemia|May 1, 1992
Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamideA Tefferi, P R Greipp, P J Leibson, et al.
Blood|February 1, 1985
Multiple myeloma: significance of plasmablastic subtype in morphological classificationP R Greipp, N M Raymond, R A Kyle, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Seminars in Oncology|September 1, 1986
Treatment of refractory multiple myeloma and considerations for future therapyR A Kyle, P R Greipp, M A Gertz
Blood|January 15, 1991
Response rates and survival in primary systemic amyloidosisM A Gertz, R A Kyle, P R Greipp
Cancer Research|August 1, 1986
Elevated glucocorticoid receptor binding in cultured human lymphoblasts following hydroxyurea treatment: lack of effect on steroid responsivenessB A Littlefield, H C Hoagland, P R Greipp
Mayo Clinic Proceedings|July 1, 1981
The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literatureR A Kyle, P R Greipp, P M Banks
Blood|August 15, 1989
The plasma cell labeling index: a valuable tool in primary systemic amyloidosisM A Gertz, R A Kyle, P R Greipp
Medical and Pediatric Oncology|January 1, 1989
Phase II trial of amsacrine in patients with multiple myelomaP R Greipp, M Coleman, K Anderson, et al.
Leukemia & Lymphoma|June 1, 2000
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disordersT E Witzig, C Meyers, T Therneau, et al.
American Journal of Hematology|May 20, 1998
Primary plasmacytoma at the site of exit wounds after electrical injuryW Mongkonsritragoon, R A Kyle, R R Shreck, et al.
Leukemia|May 1, 1992
Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamideA Tefferi, P R Greipp, P J Leibson, et al.
Blood|February 1, 1985
Multiple myeloma: significance of plasmablastic subtype in morphological classificationP R Greipp, N M Raymond, R A Kyle, et al.
Pageof 18